These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia. Ayyildiz O, Isikdogan A, Bolaman Z, Muftuoglu E. Saudi Med J; 2004 Dec; 25(12):2054-6. PubMed ID: 15711709 [No Abstract] [Full Text] [Related]
11. Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy. Garratty G, Petz LD. Br J Haematol; 2007 Nov; 139(4):622-3. PubMed ID: 17979948 [No Abstract] [Full Text] [Related]
13. Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL. Desmond R, Lynch K, Gleeson M, Farrell M, Murphy P. Am J Hematol; 2010 Aug; 85(8):607. PubMed ID: 20029990 [No Abstract] [Full Text] [Related]
14. R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia. Tonino SH, van Gelder M, Eldering E, van Oers MH, Kater AP. Leukemia; 2010 Mar; 24(3):652-4. PubMed ID: 19956201 [No Abstract] [Full Text] [Related]
16. Chronic lymphocytic leukemia in the next decade: where do we go from here? Keating MJ. Semin Hematol; 1998 Jul; 35(3 Suppl 3):27-33. PubMed ID: 9685177 [No Abstract] [Full Text] [Related]
19. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia]. Telek B, Batár P, Uvardy M. Orv Hetil; 2005 Aug 21; 146(34):1791-3. PubMed ID: 16184881 [Abstract] [Full Text] [Related]